Investigating the role of Sterol C24-Methyl transferase mutation on drug resistance in leishmaniasis and identifying potential inhibitors

References

• Abuowarda, M., AbuBakr, H. O., Ismael, E., Shaalan, M., Mohamed, M. A., & Aljuaydi, S. H. (2021). Epidemiological and genetic characteristics of asymptomatic canine leishmaniasis and implications for human Leishmania infections in Egypt. Zoonoses and Public Health, 68(5), 413–430. https://doi.org/10.1111/zph.12824
   PubMed Web of Science ®Google Scholar
• Ajmal, A., Ali, Y., Khan, A., Wadood, A., & Rehman, A. U. (2022). Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signaling. Journal of Biomolecular Structure & Dynamics, 1–10. https://doi.org/10.1080/07391102.2022.2138550
   Google Scholar
• Bekhit, A. A., Lodebo, E. T., Hymete, A., Ragab, H. M., Bekhit, S. A., Amagase, K., Batubara, A., Abourehab, M. A., Bekhit, A. E.-D A., & Ibrahim, T. M. (2022). New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: Synthesis, biological evaluation and molecular modelling simulations. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 2320–2333. https://doi.org/10.1080/14756366.2022.2117316
   PubMed Web of Science ®Google Scholar
• Brotherton, M.-C., Bourassa, S., Légaré, D., Poirier, G. G., Droit, A., & Ouellette, M. (2014). Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum. International Journal for Parasitology. Drugs and Drug Resistance, 4(2), 126–132. https://doi.org/10.1016/j.ijpddr.2014.05.002
   PubMed Web of Science ®Google Scholar
• Case, D. A., Aktulga, H. M., Belfon, K., Ben-Shalom, I., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., III, Cruzeiro, V. W. D., Darden, T. A., & Duke, R. E. (2021). Amber 2021. University of California.
   Google Scholar
• Chan-Bacab, M. J., & Peña-Rodríguez, L. M. (2001). Plant natural products with leishmanicidal activity. Natural Product Reports, 18(6), 674–688.
   PubMed Web of Science ®Google Scholar
• Chawla, B., & Madhubala, R. (2010). Drug targets in Leishmania. Journal of Parasitic Diseases, 34(1), 1–13. https://doi.org/10.1007/s12639-010-0006-3
   PubMedGoogle Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• de Menezes, J. P. B., Guedes, C. E. S., Petersen, A. L. d O. A., Fraga, D. B. M., & Veras, P. S. T. (2015). Advances in development of new treatment for leishmaniasis. BioMed Research International, 2015, 815011–815023. https://doi.org/10.1155/2015/815023
   Web of Science ®Google Scholar
• Dhamnetiya, D., Jha, R. P., & Bhattacharyya, K. (2021). India’s performance in controlling Visceral Leishmaniasis as compared to Brazil over past three decades: Findings from global burden of disease study. Journal of Parasitic Diseases, 45, 1–10.
   Google Scholar
• Diallo, B., Glenister, M., Musyoka, T. M., Lobb, K., & Tastan Bishop, Ö. (2021). SANCDB: An update on South African natural compounds and their readily available analogs. Journal of Cheminformatics, 13(1), 37. https://doi.org/10.1186/s13321-021-00514-2
   PubMed Web of Science ®Google Scholar
• Dutta, K., Elmezayen, A. D., Al-Obaidi, A., Zhu, W., Morozova, O. V., Shityakov, S., & Khalifa, I. (2021). Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations. Journal of Molecular Structure, 1246, 131113. https://doi.org/10.1016/j.molstruc.2021.131113
   PubMed Web of Science ®Google Scholar
• Dym, O., Eisenberg, D., & Yeates, T. (2006). VERIFY3D.
   Google Scholar
• Feasey, N., Wansbrough-Jones, M., Mabey, D. C., & Solomon, A. W. (2010). Neglected tropical diseases. British Medical Bulletin, 93(1), 179–200. https://doi.org/10.1093/bmb/ldp046
   PubMed Web of Science ®Google Scholar
• Geng, C., Xue, L. C., Roel‐Touris, J., & Bonvin, A. M. (2019). Finding the ΔΔG spot: Are predictors of binding affinity changes upon mutations in protein–protein interactions ready for it? Wiley Interdisciplinary Reviews 9(5), e1410.
   Google Scholar
• Goto, Y., Bhatia, A., Raman, V. S., Vidal, S. E., Bertholet, S., Coler, R. N., Howard, R. F., & Reed, S. G. (2009). Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection. Vaccine, 27(21), 2884–2890. https://doi.org/10.1016/j.vaccine.2009.02.079
   PubMed Web of Science ®Google Scholar
• Guterres, H., Park, S. J., Zhang, H., Perone, T., Kim, J., & Im, W. (2022). CHARMM‐GUI high‐throughput simulator for efficient evaluation of protein–ligand interactions with different force fields. Protein Science, 31(9), e4413. https://doi.org/10.1002/pro.4413
   Web of Science ®Google Scholar
• Hatherley, R., Brown, D. K., Musyoka, T. M., Penkler, D. L., Faya, N., Lobb, K. A., & Tastan Bishop, Ö. (2015). SANCDB: A South African natural compound database. Journal of Cheminformatics, 7(1), 29. (https://doi.org/10.1186/s13321-015-0080-8
   PubMedGoogle Scholar
• Hu, H., Chen, B., Zheng, D., & Huang, G. (2020). Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods. PeerJournal 8, e9241. https://doi.org/10.7717/peerj.9241
   Google Scholar
• Huai, Z., Shen, Z., & Sun, Z. (2021). Binding thermodynamics and interaction patterns of inhibitor-major urinary protein-I binding from extensive free-energy calculations: Benchmarking AMBER force fields. Journal of Chemical Information and Modeling, 61(1), 284–297. https://doi.org/10.1021/acs.jcim.0c01217
   PubMed Web of Science ®Google Scholar
• Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2
   PubMed Web of Science ®Google Scholar
• Kalita, S., Shaik, S., & Dubey, K. D. (2021). MD simulations and QM/MM calculations reveal the key mechanistic elements which are responsible for the efficient C–H amination reaction performed by a bioengineered P450 enzyme. Chemical Science, 12(43), 14507–14518. https://doi.org/10.1039/d1sc03489h
   PubMed Web of Science ®Google Scholar
• Khalak, Y., Tresadern, G., Aldeghi, M., Baumann, H. M., Mobley, D. L., de Groot, B. L., & Gapsys, V. (2021). Alchemical absolute protein–ligand binding free energies for drug design. Chemical Science, 12(41), 13958–13971. https://doi.org/10.1039/d1sc03472c
   PubMed Web of Science ®Google Scholar
• Kim, D. E., Chivian, D., & Baker, D. (2004). Protein structure prediction and analysis using the Robetta server. Nucleic Acids Research, 32(Web Server issue), W526–W531. https://doi.org/10.1093/nar/gkh468
   PubMed Web of Science ®Google Scholar
• Lainson, R., & Shaw, J. (2010). New world leishmaniasis, Topley & Wilson’s microbiology and microbial infections. John Wiley & Sons, Ltd.
   Google Scholar
• Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side‐chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78(8), 1950–1958. https://doi.org/10.1002/prot.22711
   PubMed Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85. https://doi.org/10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Mesh Ewald, P. (1993). An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics 98, 10089–10092.
   Web of Science ®Google Scholar
• Mhaidi, I., Ait Kbaich, M., El Kacem, S., Daoui, O., Akarid, K., Spitzova, T., Halada, P., Dvorak, V., & Lemrani, M. (2022). Entomological study in an anthroponotic cutaneous leishmaniasis focus in Morocco: Fauna survey, Leishmania infection screening, molecular characterization and MALDI‐TOF MS protein profiling of relevant Phlebotomus species. Transboundary and Emerging Diseases, 69(3), 1073–1083. https://doi.org/10.1111/tbed.14064
   PubMed Web of Science ®Google Scholar
• Mukherjee, S., Xu, W., Hsu, F. F., Patel, J., Huang, J., & Zhang, K. (2019). Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major. Molecular Microbiology, 111(1), 65–81. https://doi.org/10.1111/mmi.14139
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2000). Modification of the generalized Born model suitable for macromolecules. The Journal of Physical Chemistry B, 104(15), 3712–3720. https://doi.org/10.1021/jp994072s
   Web of Science ®Google Scholar
• Origin. origin(pro). (2021). From OriginLab Corporation.
   Google Scholar
• Pountain, A. W., Weidt, S. K., Regnault, C., Bates, P. A., Donachie, A. M., Dickens, N. J., & Barrett, M. P. (2019). Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites. PLoS Neglected Tropical Diseases, 13(2), e0007052. https://doi.org/10.1371/journal.pntd.0007052
   PubMed Web of Science ®Google Scholar
• Pourshafie, M., Morand, S., Virion, A., Rakotomanga, M., Dupuy, C., & Loiseau, P. M. (2004). Cloning of S-adenosyl-l-methionine: C-24-Δ-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-resistant promastigotes. Antimicrobial Agents and Chemotherapy, 48(7), 2409–2414. https://doi.org/10.1128/AAC.48.7.2409-2414.2004
   PubMed Web of Science ®Google Scholar
• Purkait, B., Kumar, A., Nandi, N., Sardar, A. H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., Singh, D., & Das, P. (2012). Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrobial Agents and Chemotherapy, 56(2), 1031–1041. https://doi.org/10.1128/AAC.00030-11
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. III, (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., Lescrinier, E., Marimuthu, P., Mirza, M. U., Mustafa, G., Nunes-Alves, A., Pantsar, T., Saadabadi, A., Singaravelu, K., & Vanmeert, M. (2020). Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes, 9(1), 71. https://doi.org/10.3390/pr9010071
   Web of Science ®Google Scholar
• Salomon-Ferrer, R., Gotz, A. W., Poole, D., Le Grand, S., & Walker, R. C. (2013). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. Journal of Chemical Theory and Computation, 9(9), 3878–3888. https://doi.org/10.1021/ct400314y
   PubMed Web of Science ®Google Scholar
• Sarukhanyan, E., Shityakov, S., & Dandekar, T. (2019). Rational drug design of Axl tyrosine kinase type I inhibitors as promising candidates against cancer. Frontiers in Chemistry, 7, 920. https://doi.org/10.3389/fchem.2019.00920
   PubMed Web of Science ®Google Scholar
• Shityakov, S., Fischer, A., Su, K.-P., Hussein, A. A., Dandekar, T., & Broscheit, J. (2020). Novel approach for characterizing propofol binding affinities to serum albumins from different species. ACS Omega, 5(40), 25543–25551. https://doi.org/10.1021/acsomega.0c01295
   PubMed Web of Science ®Google Scholar
• Sundar, S., Singh, A., Rai, M., Prajapati, V. K., Singh, A. K., Ostyn, B., Boelaert, M., Dujardin, J.-C., & Chakravarty, J. (2012). Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clinical Infectious Diseases, 55(4), 543–550. https://doi.org/10.1093/cid/cis474
   PubMed Web of Science ®Google Scholar
• The PyMOL Molecular Graphics System, V. S., LLC. (2021).
   Google Scholar
• Tian, W., Chen, C., Lei, X., Zhao, J., & Liang, J. (2018). CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Research, 46(W1), W363–W367. https://doi.org/10.1093/nar/gky473
   PubMed Web of Science ®Google Scholar
• Vijayakumar, S., & Das, P. (2018). Recent progress in drug targets and inhibitors towards combating leishmaniasis. Acta Tropica, 181, 95–104. https://doi.org/10.1016/j.actatropica.2018.02.010
   PubMed Web of Science ®Google Scholar
• Wang, W., Ye, W., Jiang, C., Luo, R., & Chen, H. F. (2014). New force field on modeling intrinsically disordered proteins. Chemical Biology & Drug Design, 84(3), 253–269. https://doi.org/10.1111/cbdd.12314
   PubMed Web of Science ®Google Scholar
• WHO. (2021). Neglected tropical diseases. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/leishmaniasis
   Google Scholar
• WHO. (2021). WHO report on global surveillance of epidemic-prone infectious diseases. https://apps.who.int/iris/handle/10665/66485
   Google Scholar
• Williams, T., & Kelley, C. (1986). GNUPLOT: An interactive plotting program: User manual.
   Google Scholar
• Wyllie, S., Thomas, M., Patterson, S., Crouch, S., De Rycker, M., Lowe, R., Gresham, S., Urbaniak, M. D., Otto, T. D., Stojanovski, L., Simeons, F. R. C., Manthri, S., MacLean, L. M., Zuccotto, F., Homeyer, N., Pflaumer, H., Boesche, M., Sastry, L., Connolly, P., … Gilbert, I. H. (2018). Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Nature, 560(7717), 192–197. https://doi.org/10.1038/s41586-018-0356-z
   PubMed Web of Science ®Google Scholar
• Xu, L., Sun, H., Li, Y., Wang, J., & Hou, T. (2013). Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. The Journal of Physical Chemistry. B, 117(28), 8408–8421. https://doi.org/10.1021/jp404160y
   PubMed Web of Science ®Google Scholar
• Yadav, S., Pandey, S. K., Singh, V. K., Goel, Y., Kumar, A., & Singh, S. M. (2017). Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies. PloS One, 12(5), e0176403. https://doi.org/10.1371/journal.pone.0176403
   PubMed Web of Science ®Google Scholar
• Yang, J., & Zhang, Y. (2015). I-TASSER server: New development for protein structure and function predictions. Nucleic Acids Research, 43(W1), W174–W181. https://doi.org/10.1093/nar/gkv342
   PubMed Web of Science ®Google Scholar
• Zwanzig, R. (1973). Nonlinear generalized Langevin equations. Journal of Statistical Physics, 9(3), 215–220. https://doi.org/10.1007/BF01008729
   Google Scholar